Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:04 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | 1,918,392 | $0 | 1,918,392 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:03 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 1,721,328 | $0 | 1,721,328 (Direct) | View |
| 2021-11-17 Disposition | 2021-11-19 1:22 pm | N/A 2030-12-23 | Trillium Therapeutics Inc. | TRIL | TAYTON-MARTIN HELEN KATRINA Director | 538,294 | $0 | 0 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-03 9:01 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 1,785,000 | $0.157 | 1,800,000 (Direct) | View |
| 2021-01-11 Option Award | 2021-01-11 9:01 pm | N/A 2031-01-11 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 1,329,528 | $0 | 1,329,528 (Direct) | View |
Ownership | 2021-01-04 8:08 pm | N/A 2030-12-23 | Trillium Therapeutics Inc. | TRIL | TAYTON-MARTIN HELEN KATRINA Director | 0 | $0 | 538,294 (Direct) | View |
| 2020-01-16 Option Award | 2020-01-17 9:35 pm | N/A 2030-01-16 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 1,538,640 | $0 | 1,538,640 (Direct) | View |